RBM47 and glioma: Comparable findings were replicated in the TCGA database (Fig. 3E–H), reinforcing the notion that RBM47 plays a pivotal role in modulating immunity, inflammation, immune-mediated disorders, as well as the intricate glioma microenvironment.